Abstract
Using a citizen science approach, we identify a country-wide exposure to aerosolized spores of a human fungal pathogen, Aspergillus fumigatus, that has acquired resistance to the agricultural fungicide tebuconazole and first-line azole clinical antifungal drugs. Genomic analysis shows no distinction between resistant genotypes found in the environment and in patients, indicating that at least 40% of azole-resistant A. fumigatus infections are acquired from environmental exposures. Hotspots and coldspots of aerosolized azole-resistant spores were not stable between seasonal sampling periods. This suggests a high degree of atmospheric mixing resulting in an estimated per capita cumulative annual exposure of 21 days (±2.6). Because of the ubiquity of this measured exposure, it is imperative thatwe determine sources of azole-resistant A. fumigatus to reduce treatment failure in patients with aspergillosis.
Original language | English |
---|---|
Article number | adh8839 |
Journal | Science Advances |
Volume | 9 |
Issue number | 29 |
DOIs | |
Publication status | Published - Jul 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors.